Simply Wall Street Earnings
Do Strong Q3 Results And Bigger Credit Lines Change The Bull Case For Cencora (COR)?
Cencora (COR) recently reported strong Q3 2026 results with $84.75 billion in sales and $763.52 million in net income, alongside declaring a $0.60 quarterly dividend. The company also expanded its multi-currency credit facility to $7.00 billion with maturities extended to 2031, reinforcing its financial flexibility. These developments support Cencora's investment narrative focused on scale in pharmaceutical distribution and …